Company Overview
American Healthcare Capital is proud to exclusively represent a growth-stage medical device and technology manufacturing company that is providing transformative solutions to a global healthcare crisis rooted in chronic, lifestyle-related diseases. Conditions like ALS, COPD, Heart Failure, Arthritis, and Type 2 Diabetes continue to grow at unsustainable rates, yet most patients are unable to engage in the physical activity necessary for prevention and recovery. Our client’s patented FDA approved vacuum chamber methodology medical equipment device and technology delivers a novel form of non-invasive therapy that simulates the benefits of high-intensity exercise and altitude training through rapid vacuum pressure changes.
Delivered passively in 20-minute sessions, the system activates biological pathways associated with improved metabolic function, increased oxygen utilization, and enhanced cellular health. Over 600,000 sessions have been completed to date with no reported significant adverse events.
Scientific validation from respected institutions, such as the Mayo Clinic and Cedar-Sinai hospital, confirms efficacy in glucose metabolism and VO2 max improvement. Early case reports and testimonials also indicate potential in neurodegenerative disease support, including ALS. Public figures in wellness and performance optimization have endorsed its value through personal ownership and use.
Targeting a multibillion-dollar addressable market, including physical therapy clinics, integrative medicine, and performance recovery, the technology is already generating recurring revenue and is reimbursable under existing insurance codes. Clinics using the system report significant ROI and increased patient volume. The company has generated a total of $7 million in aggregated sales volume, validating commercial feasibility and further endorsed by a well-known celebrity-customer.
Asking Price
The asking price is to be determined through discussion and negotiation. The seller is open to a range of transactional structures, including an outright sale to a strategic buyer or a sale of a majority interest to a private equity buyer while staying on with both types of buyers with the intent to scale the company on a worldwide basis.
